Abstract
A 9-valent human papillomavirus (HPV) vaccine, licensed in 2014, prevents 4 HPV types targeted by the quadrivalent vaccine (6/11/16/18) and 5 additional high-risk (HR) types (31/33/45/52/58). Measuring seropositivity before vaccine introduction provides baseline data on exposure to types targeted by vaccines. We determined seroprevalence of HPV 6/11/16/18/31/33/45/52/58 among 4943 persons aged 14-59 years who participated in the National Health and Nutrition Examination Survey, 2005-2006. Among females, seroprevalence was 40.5% for any of the 9 vaccine types, 30.0% for any 7 HR types (16/18/31/33/45/52/58), 19.0% for any 5 additional types (31/33/45/52/58), and 18.3% for 16/18. Compared with non-Hispanic whites, non-Hispanic blacks had higher seroprevalence of 31/33/45/52/58 (36.8% vs 15.9%) and 16/18 (30.1% vs 17.8%), while Mexican Americans had higher seroprevalence of 31/33/45/52/58 (23.6% vs 15.9%) (P < .05 for all). In multivariable analyses of data from females, race/ethnicity, number of sex partners, and age were associated with 16/18 and 31/33/45/52/58 seropositivity. Seropositivity was lower among males than among females (P < .001 for all type categories). In 2005-2006, about 40% of females and 20% of males had serolo...Continue Reading
References
Jun 6, 2000·The Journal of Infectious Diseases·J J CarterD A Galloway
Oct 24, 2007·The Journal of Infectious Diseases·Jeffrey M PartridgeLaura A Koutsky
Oct 24, 2007·The Journal of Infectious Diseases·Anna R GiulianoRobin B Harris
Sep 2, 2009·The Journal of Infectious Diseases·Lauri E MarkowitzElizabeth R Unger
Oct 19, 2010·The Lancet Oncology·Silvia de SanjoseUNKNOWN Retrospective International Survey and HPV Time Trends Study Group
Jun 16, 2011·The Journal of Infectious Diseases·Zoe R EdelsteinLaura A Koutsky
Sep 9, 2011·Journal of the National Cancer Institute·Hui-Chi ChenUNKNOWN CBCSP-HPV Study Group
Feb 11, 2012·International Journal of Cancer. Journal International Du Cancer·Peng GuanGary M Clifford
Jun 26, 2012·International Journal of Cancer. Journal International Du Cancer·Long Fu XiNancy B Kiviat
Oct 10, 2012·The Journal of Infectious Diseases·Susan HaririUNKNOWN HPV-IMPACT Working Group
Dec 5, 2012·Vaccine·David FormanSilvia Franceschi
Dec 5, 2012·Vaccine·John T SchillerSuzanne M Garland
Dec 5, 2012·Vaccine·John DoorbarMargaret A Stanley
Jan 1, 2013·Infectious Agents and Cancer·Beatriz SerranoSilvia de Sanjosé
Feb 14, 2013·Sexually Transmitted Diseases·Catherine Lindsey SatterwhiteHillard Weinstock
Jun 1, 2013·Journal of Medical Virology·Madelief MollersHester E de Melker
Apr 22, 2014·Sexually Transmitted Infections·Camille E IntrocasoLauri E Markowitz
Oct 10, 2014·Sexually Transmitted Diseases·Harrell W ChessonLauri E Markowitz
Nov 25, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Susan HaririLauri E Markowitz
Nov 27, 2014·Human Vaccines & Immunotherapeutics·Christine RobertsJoseph Antonello
Dec 17, 2014·Sexually Transmitted Diseases·Gui LiuLauri E Markowitz
Feb 19, 2015·The New England Journal of Medicine·Elmar A JouraUNKNOWN Broad Spectrum HPV Vaccine Study
May 1, 2015·Journal of the National Cancer Institute·Mona SaraiyaUNKNOWN HPV Typing of Cancers Workgroup
Citations
Feb 6, 2016·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Walter W WilliamsCarolyn B Bridges
Sep 1, 2015·The Journal of Infectious Diseases·Patti E Gravitt
Mar 25, 2016·The Journal of Infectious Diseases·Aaron C Ermel, Kenneth H Fife
Dec 3, 2016·The Journal of General Virology·Shams RahmanAnna R Giuliano
Apr 28, 2017·Epidemiology and Infection·C SignorelliA Peracino
Feb 9, 2017·The Journal of Infectious Diseases·Patti E Gravitt
May 5, 2017·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Walter W WilliamsAmy Parker Fiebelkorn
Dec 3, 2016·PloS One·Shams RahmanAnna R Giuliano
Mar 13, 2018·The Journal of Infectious Diseases·Hanna ArtemchukHelena Faust
Sep 7, 2017·Sexually Transmitted Diseases·S Lee WareMichael E Hagensee
Jun 28, 2018·Genes & Development·Erica A GolemisNancy Hopkins
Nov 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rayleen M LewisElizabeth R Unger
Mar 12, 2016·Sexually Transmitted Diseases·Eleni Marie RettigPatti Gravitt
Feb 23, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Admire ChikandiwaSinead Delany-Moretlwe
Sep 23, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Navkiran K ShokarAlok Dwivedi
Jan 19, 2018·Oncology Letters·Edoardo TartagliaClaudio Ucciferri
Sep 16, 2016·Sexually Transmitted Diseases·Gui LiuLauri E Markowitz
Aug 31, 2019·Epidemiology and Infection·Reyna Lizette Pacheco-DomínguezMalaquías López-Cervantes
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alexis J PillsburyJulia M L Brotherton
Aug 29, 2020·Vaccines·Mauro TognonFernanda Martini
Sep 22, 2017·The Journal of Infectious Diseases·Marc D RyserPatti E Gravitt
Jan 12, 2021·Human Vaccines & Immunotherapeutics·Vincent DanielsElamin Elbasha
Oct 9, 2020·Obstetrics and Gynecology·Lital Avni-SingerSangini S Sheth
Jan 15, 2018·Cytotherapy·Sarah E McCormackCatherine M Bollard
Mar 16, 2021·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Lital Avni-SingerSangini S Sheth
Jul 16, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph E TotaJoel M Palefsky
Feb 26, 2016·Chemical Research in Toxicology·Mina YeomJeong-Yun Choi